The impact of cost-effectiveness of country specific application-the case of drotrecogin alfa (activated) in severe sepsis

被引：0
|
作者：
Persson, U
Hjelmgren, J
Ragnarson, TG
Davies, A
机构：
[1] IHE, Lund, Sweden
[2] Medtap Int, London, England
来源：
VALUE IN HEALTH | 2003年 / 6卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)61917-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：752 / 753
页数：2
相关论文
共 50 条
  • [11] Cost-effectiveness of drotrecogin alfa (activated)
    Tsitanidis, J
    CRITICAL CARE MEDICINE, 2003, 31 (09) : 2414 - 2415
  • [12] Cost effectiveness analysis of drotrecogin alfa (activated) as a treatment for severe sepsis
    Launois, R
    Riou-Franca, L
    Guidet, B
    Aergeter, P
    Meshaka, P
    Pinton, P
    INTENSIVE CARE MEDICINE, 2002, 28 : S161 - S161
  • [13] Cost-effectiveness of drotrecogin alfa (activated) - Reply
    Angus, DC
    Linde-Zwirble, WT
    CRITICAL CARE MEDICINE, 2003, 31 (09) : 2415 - 2415
  • [14] Cost effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom
    Davies, A
    Ridley, S
    Hutton, J
    Chinn, C
    Barber, B
    Angus, DC
    ANAESTHESIA, 2005, 60 (02) : 155 - 162
  • [15] Impact of the number of failed organs on the cost-effectiveness of drotrecogin alfa (activated)
    Betancourt, M
    McKinnon, PS
    Devlin, JW
    Kanji, S
    Bach, DS
    Massanari, RM
    INTENSIVE CARE MEDICINE, 2002, 28 : S160 - S160
  • [16] Assessing the cost-effectiveness of drotrecogin all (activated) in severe sepsis in Poland
    Jakubczyk, M
    Kowalik, E
    Newada, M
    Kübler, A
    Lis, J
    Kamiñski, B
    VALUE IN HEALTH, 2004, 7 (06) : 763 - 763
  • [17] Cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in Germany (vol 18, pg 217, 2004)
    Neilson
    Burchardi
    Chinn
    JOURNAL OF CRITICAL CARE, 2004, 19 (01) : 66 - 66
  • [18] Cost effectiveness analysis of drotrecogin alfa (activated) as a treatment for severe sepsis in hospitalised patients
    R Launois
    L Riou Franca
    B Guidet
    P Aegerter
    X Huet
    P Meshaka
    P Pinton
    Critical Care, 6 (Suppl 1):
  • [19] Drotrecogin alfa (activated) in severe sepsis
    Baillie, JK
    Murray, G
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01): : 95 - 95
  • [20] Drotrecogin alfa (activated) in severe sepsis
    Janes, Jonathan M.
    Vangerow, Burkhard
    Costigan, Timothy M.
    Macias, William L.
    LANCET INFECTIOUS DISEASES, 2013, 13 (02): : 108 - 109
12345